This repository is under review for potential modification in compliance with Administrative directives.

Regional Distribution of COVID+ Patients

This dashboard shows the regional distribution of COVID+ patients within the Enclave and the number of contributing sites in each region.

Filters



Data as of Oct 10, 2024 (v185)

Total Patients
8.02M
Patients in Multiple States
(Not On Map)
468.86k
Number of Providers
85

Regional Distribution of COVID+ Patients

load

Sample: COVID+ patients , or patients who have had, a laboratory-confirmed positive COVID-19 PCR or Antigen test, a laboratory-confirmed positive COVID-19 Antibody test, or a Medical visit in which the ICD-10 code for COVID-19 (U07.1) was recorded  in the N3C Data Enclave. Regions are colored by the total number of patients associated with providers located in that region, as patient location is frequently missing. In most states, only one hospital system is represented. This does not constitute a representative sample of any geographic region and cannot be used to calculate the rate of infection for that region. Several sites contributing data to the Enclave are not represented on this map. This is either a result of the site contributing data pertaining to multiple states or because the site is still in the process of being mapped. For additional information, see limitations below.

Learn More about Census Regions

This data contains all COVID+ patients in the N3C Data Enclave.

 

A COVID-positive patient is defined as any patient having one of the following within their EHR records:

  1. Laboratory confirmed positive COVID-19 PCR or Antigen test
  2. Laboratory confirmed positive COVID-19 Antibody test
  3. Medical visit in which the ICD-10 code for COVID-19 (U07.1) was recorded
    • Condition diagnosis patients have no record of a positive PCR/Antigen or Antibody test within their EHR; however, they were diagnosed with COVID due to the symptoms they displayed.

A Patient’s Region is defined based on the US Census Region of the hospital providing their EHR data.

  • This does not necessarily equate to the region that the patient resides in.
  • This does not constitute a representative sample of any geographic region and cannot be used to calculate the rate of infection for that region.

Severity of COVID-19 is a calculation based on multiple events recorded in a patient's EHR during their medical visit. The severity score for each patient may be inaccurate due to missing information within the EHR. Patients will only be graded on Severity if they have a laboratory-confirmed positive PCR or Antigen test. Below are the definitions of each Severity Category.

  • Mild - The patient has no record of Emergency Room visits or hospitalization for COVID-19
  • ED Visit (not admitted) - The patient had an Emergency Room (ER) visit for COVID-19, but we have no record of hospitalization (Inpatient) for COVID-19
  • Moderate Hospitalized - The patient was hospitalized (Inpatient visit) for COVID-19 AND did not receive ECMO OR Invasive Ventilation
  • Mortality - The patient’s records show a date of death
  • Severe Ventilation/ECMO/AKI - The patient was hospitalized for COVID-19 AND received Extracorporeal membrane oxygen (ECMO) OR received Invasive Ventilation
  • Unavailable - Patients who did not have a lab-confirmed positive PCR or Antigen COVID test. This includes patients who were diagnosed only based on the symptoms they displayed or patients who do not have any recorded COVID-19 diagnosis within the Enclave.

General Enclave Limitations

  • “Sicker” patients will likely be overrepresented within the N3C Data Enclave, as sicker patients will more often seek out and receive care at clinical centers.
  • The N3C may have multiple contributors to data “missingness”. Clinical facts and events that occur in the real world may not be captured for reasons including:
    • The event was recorded at a clinical site that does not contribute data
    • Data is not yet linked across sites
    • Medical records are inherently incomplete
  • Some of the external datasets that have been used for analysis cannot be fully mapped due to issues such as missing measurement units.
  • All dates within the Enclave have been shifted between -3 to 45 days to ensure that reidentification is not possible.
  • N3C data may not be representative of the entire US population
    • N3C does NOT have a representative sample of any state, as data is contributed from only a few providers in each region (Region - includes multiple states).
  • Cell sizes smaller than 20 people have been suppressed
  • For COVID+ patients: A patient is only counted once in this data, even if they have multiple positive tests over time. Except in instances where dashboards focus on reinfection, only dates of first infection are utilized.